Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance | Synapse
March 3, 2026
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired and diabetic glucose tolerance
Key Points
Patients with cystic fibrosis show different hormone responses to oral glucose compared to those with normal glucose tolerance and diabetes.
Glucagon levels were measured following interventions, revealing significant variability among glucose tolerance groups.
Analysis assessed hormonal responses using a comparison of oral glucose and intravenous glucagon in cystic fibrosis.
Findings may guide future management strategies for glucose intolerance in cystic fibrosis patients.